LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients

NCT06576635 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Docetaxel
DRUG: Paclitaxel
DRUG: Gemcitabine
DRUG: Pemetrexed
DRUG: Vinorelbine

Sponsor

University of Illinois at Chicago